The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure.

Alexander A Berezin, Zeljko Obradovic, Ivan M Fushtey, Tetiana A Berezina, Evgen V Novikov, Lukas Schmidbauer, Michael Lichtenauer (Co-author), Alexander E Berezin

Research output: Contribution to journalOriginal Articlepeer-review

10 Citations (Web of Science)
Original languageEnglish
JournalBIOMEDICINES
Volume11
Issue number2
DOIs
Publication statusPublished - 2023

Keywords

  • GLUCOSE COTRANSPORTER-2 INHIBITORS
  • REDUCED EJECTION FRACTION
  • DISEASE
  • IRISIN
  • RISK
  • HOMEOSTASIS
  • MORTALITY
  • OBESITY

Cite this